Toyama Mio, Hasegawa Takashi, Sakagami Takuro, Koya Toshiyuki, Hayashi Masachika, Kagamu Hiroshi, Muramatsu Yoshiyuki, Muramatsu Kumiko, Arakawa Masaaki, Gejyo Fumitake, Narita Ichiei, Suzuki Eiichi
Division of Respiratory Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Department of General Medicine, Niigata University Medical and Dental Hospital, Niigata, Japan.
Allergol Int. 2014 Dec;63(4):587-94. doi: 10.2332/allergolint.14-OA-0708. Epub 2014 Aug 25.
Depression has been linked to poorer asthma control in asthmatic patients. Although the Japanese version of the Asthma Control Test (ACT-J) is frequently used as a simple, practical evaluation tool in clinical care settings in Japan, knowledge regarding its efficacy for assessing asthma control in asthmatic patients with depression is limited. Thus, we retrospectively investigated cut-off values of the ACT-J for well-controlled asthma, and explored depression's influence on the test with a questionnaire survey.
Data were analyzed on 1,962 adult asthmatic patients who had completed both the ACT-J and the Japanese version of the Patient Health Questionnaire-9 (J-PHQ-9) in 2008 questionnaire survey conducted by the Niigata Asthma Treatment Study Group. Patients were classified into low (LD: J-PHQ-9 score of 0-4) or high depression (HD: J-PHQ-9 score of 5-27) groups. In both groups, the efficacy of the ACT-J was confirmed. We then compared the optimal cut-off points for uncontrolled asthma in both groups by performing a receiver operating characteristic (ROC) analysis, using the original classification referred to the GINA classification as the "true" classification.
Cronbach's alpha in the LD and HD group was 0.808 and 0.740 respectively. In both groups, the sub-group with existence of work absenteeism or frequent attacks during the previous 12 months scored lower on the ACT-J. The area under the curve and optimal cut-off point for patients with LD and HD were 0.821 and 0.846, and 23 and 20 respectively.
The efficacy of the ACT-J was confirmed in depressive patients with asthma. Because asthma control as evaluated with the ACT-J can be worse than actual control under depressive states, physicians should also pay attention to a patient's depressive state at evaluation. Further investigations focus on the association between the ACT-J and depression are required.
抑郁症与哮喘患者较差的哮喘控制相关。尽管日语版哮喘控制测试(ACT-J)在日本临床护理环境中经常被用作一种简单、实用的评估工具,但关于其在评估合并抑郁症的哮喘患者哮喘控制方面的有效性的知识有限。因此,我们进行了回顾性研究,调查了ACT-J用于哮喘控制良好的临界值,并通过问卷调查探讨了抑郁症对该测试的影响。
对新潟哮喘治疗研究组在2008年问卷调查中完成ACT-J和日语版患者健康问卷-9(J-PHQ-9)的1962例成年哮喘患者的数据进行分析。患者被分为低抑郁组(LD:J-PHQ-9评分为 $0 - 4$)或高抑郁组(HD:J-PHQ-9评分为 $5 - 27$)。在两组中,均证实了ACT-J的有效性。然后,我们通过进行受试者工作特征(ROC)分析,以参照全球哮喘防治创议(GINA)分类的原始分类作为“真实”分类来比较两组中未控制哮喘的最佳临界值。
LD组和HD组的Cronbach's alpha分别为0.808和0.740。在两组中,在过去12个月内存在旷工或频繁发作的亚组在ACT-J上得分较低。LD组和HD组患者的曲线下面积和最佳临界值分别为0.821和0.846,以及23和20。
ACT-J在合并抑郁症的哮喘患者中的有效性得到了证实。由于在抑郁状态下,用ACT-J评估的哮喘控制可能比实际控制更差,医生在评估时也应注意患者的抑郁状态。需要进一步研究ACT-J与抑郁症之间的关联。